J.ophthalmol.(Ukraine).2015;6:54-63.

https://doi.org/10.31288/oftalmolzh201565463

Neuro-ophthalmological aspects of idiopathic intracranial hypertension

K.S. Iegorova, doctor

L.V. Zadoiany, PhD in Medical Sciences

SI “A. P. Romodanov Institute of Neurosurgery of NAMS of Ukraine”

Kyiv (Ukraine)

E-mail: iegorova_katya@ukr.net

Keywords: idiopathic intracranial hypertension, papilledema, secondary optic atrophy.

 

References

  1. Bessmertnyiy M.Z. The mechanism of occurrence of papilledema in acute closed craniocerebral injury. Vestnik oftalmologii. 2002; 1: 36–38. Russian.
  2. Gasparyan S.S. The clinic, diagnosis and treatment of patients with the syndrome of benign intracranial hypertension : author’s thesis for Doctor of Medical Sciences. 14.00.28. Neurosurgery. Moscow. 1998. 246 p.
  3. Golenkov A.K. Retinal venous pulse. Kaluga: «Mikrohirurgiya glaza».1992. 107 p. 
  4. Merkulov I.I Clinical Ophthalmology . Optic nerve. Erevan: Ayastan; 1979. 222p. Russian.
  5. Muhamadiev P.O Fluorescein angiography of the fundus with the papilledema and pseudopapilledema: author’s thesis for Candidate of Medical Sciences: 14.00.08. Moscow. 1974. 20 p.
  6. Nikitin Y. M. Ultrasonography diagnostics in neurology and neurosurgery. Moscow: Meditsina; 1987. 496p. Russian.
  7. Rykun B.C. Additional ultrasonographic criteria for the differential diagnosis of papilledema and pseudopapilledema. Journal of ophthalmology. 2006; 4:9–11. Russian.
  8. Samoilov A. J. Ophthalmological symptoms of the tumor cerebri. Мoscow: Меdgiz; 1959. 228p. Russian.
  9. Serova N.K. Clinical neuroophthalmology. Neurosurgery aspects. Tver’: Triada; 2011. 323 p. Russian.
  10. Sokolova O.N. Clinical features of papilledema and visual function causes disturbances in tumors and inflammatory processes in the brain. Modern aspects of neuroophthalmology: thesis of VI scientific neuroophthalmology conference Moscow; 2002. 33–6. Russian. 
  11. Tron E. G. Diseases of the visual pathway. Мoscow: Меdgiz; 1955. 394 p. Russian
  12. Tropinscai O. F., Serova N.K., Eliseeva N.M. The use of automatic static perimetry optic nerve is damaged in neurosurgical patients. Modern aspects of neuroophthalmology: thesis of VII scientific neuroophthalmology conference Moscow; 2003. 86. Russian.
  13. Fridman F.E. Gundarova R.A., Kodzov M.B. Ultrasound in ophthalmology. Moscow :Meditsina;1989. 256 p. Russian.
  14. Xarlap S. I. Modern ultrasonic methods of research in clinical ophthalmology. History of the problems and prospects of development. Vestnic RAMN. 2002; 2:32–38. Russian.
  15. Levin P.S., Newman S.A., Quigley H. A., Miller N.R. A clinicopathologic study of optic neuropathies associated with intracranial mass lesions with quantification of remaining axons. Am. J. Ophthalmology. 1983; 95(3): 295–306.
    Crossref
  16. Ahlskog J.E., O'Neill B.P. Pseudotumor cerebri. Annals of Intern. Medicine. 1982; 97(2): 249–56.
  17. Beck R. W. Automated perimetry: principles and practice. Int. Ophthalmol. Clin. 1986; 26(4):163–73.
  18. Rodr?guez de Rivera F.J., Martinez–Sanchez P., Ojeda–Ruiz de Luna J., Arpa–Gutierrez F.J., Barreiro–Tella P. Benign intracranial hypertension. History, clinical features and treatment in a series of 41 patients. Rev. Neurol. 2003; 37(9): 801–5.
  19. Blaivas M., Theodoro D., Sierzenski P.R. Elevated intracranial pressure detected by bedside emergency ultrasonography of optic nerve sheath. Emergency Medicine. 2003; 10(4):376–81.
  20. Brodsky M. C., Vaphiades M. Magnetic resonance imaging in pseudotumor cerebri. Ophthalmology. 1998; 105(9):1686–93.
  21. Burgett R.A., Purvin V.A., Kawasaki A. Lumboperitoneal shunting for pseudotumor cerebri. J. Neurology. 1997; 49(3):734–9.
  22. Chappell J.J. Pseudotumor cerebri following an atrial defect repair in a child. Ann. Ophthalmol. 1982; 14(12):1127–30.
  23. Chiu A. M., Chuenkongkaew W.L. Minocycline treatment and pseudotumor cerebri syndrome. American Journal of Ophthalmology. 1998; 126(1): 116–21.
  24. Cogan D.G. Neurology of the visual system. Illinois USA, 1972. 413 p.
  25. Corbett J. J. The first Jacobson Lecture. Familial idiopathic intracranial hypertension. J. Neuroophthalmol. 2008; 28(4): 337–47.
  26. Corbett J. J., Thompson H.S. The rational management of idiopathic intracranial hypertension. Arch. Neurol. 1989; 46(10): 1049–51.
  27. Craig J.J., Mulholland D.A., Gibson J.M. Idiopathic intracranial hypertension; incidence, presenting features and outcome in Northern Ireland (1991–1995). Ulster Med. J. 2001;70(1):31–35.
  28. Dandy W. E. Intracranial pressure without brain tumour; diagnosis and treatment. Ann. Surg. 1937;106(4):492–513.
  29. Digre K.B. Not so benign intracranial hypertension. BMJ. 2003; 326(7390):613–14.
  30. Duggal H. S. Idiopathic intracranial hypertension presenting with psychiatric symptoms. Journal of Neuropsychiatry Clinical Neuroscience. 2005; 17(3):426–7.
  31. Durcan F.J., Corbett J., Wall M. The incidence of pseudotumor cerebri. Populatic studies in Iowa and Louisiana. Arch. Neurol. 1988; 45(8):875–7.
  32. Kupersmith M.G., Gamell L., Turbin R., Peck V, Spiegel P, Wall M. Effects of Weight Loss on the Course of Idiopathic Intracranial Hypertension in Women. Neurology. 1998; 50(4): 1094–8.
  33. Verplanck M., Kaufman D.I., Parsons T., Yedavally S., Kokinakis D. Electrophysiology versus psychophysics in the detection of visual loss in pseudotumor cerebri. Neurology. 1988; 38(11):1789–92.
  34. Radhakrishnan K., Thacker A.K., Bohlaga N.H., Maloo J.C., Gerryo S.E. Epidemiology of idiopathic intracranial hypertension: a prospective and case– control study. J. Neurol. Sci. 1993;116(1):18–28.
  35. Asensio–Sanchez V.M., Merino–Angulo J., Martinez–Calvo S. Epidemiology of pseudotumor cerebri. Arch. Soc. Esp. Oftalmol. 2007; 82(4):219–21.
  36. Wall M., Conway M.D., House P.H., Allely R. Evaluation of sensitivity and specificity of spatial resolution and Humphrey automated perimetry in pseudotumor cerebri patients and normal subjects. Invest. Ophthalmol. Vis. Sci. 1991; 32(13):3306–12.
  37. Bakshi S.K., Oak J. L.,Chawla K.P., Kulkarni S.D., Apte N. Facial nerve involvement in pseudotumor cerebri. J. Postgrad Med. 1992; 38(3):144–5.
  38. Karaman K., Gverovic–Antunica A.,Zuljan I., Vukojevic N., Zoltner B., Erceg I., Ivkosic. Familial idiopathic intracranial hypertension. Croat. Med. J. 2003; 44(4):480–4.
  39. Fishman.R. Cerebrospinal fluid in diseases of the nervous system. Philadelphia: WB Saunders: 1992. 565p.
  40. Foley J. Benign forms of intracranial hypertension. Toxic and otitic hydrocephalus. Brain. 1955; 78(1):1–41.
  41. Friedman D.I., Jacobson D.M. Diagnostic criteria for idiopathic intracranial hypertension. Neurology. 2002; 59(10):1492–5.
  42. Friedman D.I., Jacobson D.M. Idiopathic intracranial hypertension. Journal of Neuro–Ophthalmology. 2004; 24(2):138–45.
  43. Friedman D.I. Pseudotumor cerebri. Neurosurg. Clin. N. Am. 1999; 10(4):609–21.
  44. Frisen L. Swelling of the optic nerve head: a staging scheme. J. of Neurol., Neurosurg., Psychiatry. 1982; 45(1):13–8.
  45. Thambisetty M, Lavin P.J., Newman N.J., Biousse V Fulminant idiopathic intracranial hypertension. Neurology. 2007; 68(3):229–32.
  46. Galvin J.A. ,Van Stavern G.P. Clinical Characterization of   Idiopathic Intracranial Hypertension at the Detroit Medical Centre. Journal of the Neurological Sciences. 2004; 223(2):157–60.
  47. Garton H.J. Cerebrospinal fluid diversion procedures. J. of Neuro– Ophthalmology. 2004; 24(2):146–55.
  48. Gobel W., Lieb W.E., Grein H.J. Quantitative and objective follow–up of papilledema with the Heidelberg Retina Tomograph. Ophthalmologe. 1997;94(9):673–7.
  49. Gordon K. Pediatric pseudotumor cerebri: descriptive epidemiology. Can. J. Neurol .Sci. 1997; 24(3):219–21.
  50. Grant D. N. Benign intracranial hypertension. A review of 79 cases in infancy and childhood. Arch. Dis. Child. 1971; 46(249):651–5.
  51. Greer M. Benign Intracranial Hypertension. VI. Obesity. Neurology. 1965; 15(4):382–8.
  52. Greer M. Management of benign intracranial hypertension (pseudotumor cerebri). Clin. Neurosurg. 1968;15:161–174.
  53. Griffin J. P. A review of the literature on benign intracranial hypertension associated with medication. Adverse Drug React. Toxicol. Rev. 1992; 11:41–58.
  54. Gruber H., Czech T. Computed perimetry for the follow –up of the optic neuropathy in pseudotumor cerebri. Klin. Monbl. Augenheilkd. 1990; 196:214–5.
  55. Guidetti B., Giuffr? R., D., Gambacorta D. Follow–up study of 100 cases of pseudotumor cerebri. Acta Neurochir. 1968; 18:259–67.
  56. Hayreh S.S. Optic disc edema in raised intracranial pressure. V. Pathogenesis. Arch. Ophthalmology. 1977; 95(9):1553–65.
  57. Hayreh S.S. Pathogenesis of oedema of the optic disk (papilloedema), a preliminary report. British Journal of Ophthalmology. 1964; 48:522–43.
  58. Helmke K., Hansen H. Fundamentals of transorbital sonographic evaluation of optic nerve sheath expansion under intracranial hypertension II. Patient study. Pediatr. Radiol. 1996; 26(10):706–10.
  59. Hoyt W. F., Knight C. L. Comparison of congenital disc blurring and incipient papilledema in red–free light – a photographic study. Invest Ophthalmol. 1973; 12(4):241–7.
  60. Hu K., Davis A., O’Sullivan E. Distinguishing optic disc drusen from papilloedema. BMJ. 2008; 337:a2360.
  61. Huna–Baron R., Kupersmith M.J. Idiopathic intracranial hypertension in pregnancy. J. Neurol. 2002; 249(8):1078–81.
  62. Carta A., Bertuzzi F., Cologno D., Giorgi C., Montanari E., Tedesco S. Idiopathic intracranial hypertension (pseudotumor cerebri): descriptive epidemiology, clinical features, and visual outcome in Parma, Italy, 1990 to 1999. Eur. J. Ophthalmol. 2004; 14(1):48–54.
  63. Binder D. K., Horton J. C., Lawton M. T., McDermott M. W Idiopathic intracranial hypertension. J. Neurosurgery. 2004; 54(3):538–51.
  64. Soiberman U., Stolovitch C., Balcer L.J., Regenbogen M., Constantini S., Kesler A. Idiopathic intracranial hypertension in children: visual outcome and risk of recurrence. Childs. Nerv. Syst. 2011;27(11):1913–8.
  65. Dogulu C. F., Tsilou E., Rubin B. Idiopathic intracranial hypertension in cystinosis. Journal of Pediatrics. 2004;145(5):673–8.
  66. Fujiwara S., Sawamura Y., Kato T., Abe H., Katusima H. Idiopathic intracranial hypertension in female homozygous twins. J. of Neurol., Neurosurg., Psychiatry. 1997; 62(6):652–4.
  67. Bruce B. B., Kedar S., Van Stavern G. P., Monaghan D, Acierno MD, Braswell RA, Preechawat P, Corbett JJ, Newman NJ, Biousse V. .Idiopathic intracranial hypertension in men. Neurology. 2009;72(4):304–9.
  68. Wang S.J., Silberstein S.D., Patterson S., Young W.B. Idiopathic intracranial hypertension without papilledema: a case–control study in a headache center. Neurology. 1998; 51(1):245–9.
  69. Glueck C. J., Aregawi D., Goldenberg N. Golnik K.C., Sieve L., Wang P. Idiopathic intracranial hypertension, polycystic–ovary syndrome, and thrombophilia. J. Lab. Clin. Med. 2005; 145(2):72–82.
  70. ?ncecik F., Herguner O.M., Altunbasak S. Evaluation of sixteen children with pseudotumor cerebri. Turkish J. of Pediatrics. 2011; 53(1):55–8.
  71. Yabe I., Moriwaka F., Notoya A., Ohtaki M., Tashiro K. Incidence of idiopathic intracranial hypertension in Hokkaido, the northernmost island of Japan. J. Neurol. 2000; 247(6):474–5.
  72. Ireland B. J. Corbett J.J., Wallace R.B.The search for causes of idiopathic intracranial hypertension: A preliminary case–control study. Arch. Neurol. 1990; 47(3):315–20.
  73. Kanagalingam S., Subramanian P.S. Cerebral venous sinus stenting for pseudotumor cerebri: a review. Saudi J. Ophthalmol. 2015; 29(1):1–6.
  74. Kapoor K.G. Do patients with idiopathic intracranial hypertension suffer from hyposmia? Med Hypotheses. 2008; 71(5):816–7.
  75. Karam E. Z., Hedges T. R. Optical coherence tomography of the retinal nerve fibre layer in mild papilloedema and pseudopapilloedema. Br. J. Ophthalmol. 2005; 89(3):294–8.
  76. Kesler A., Gadoth N. Epidemiology of idiopathic intracranial hypertension in Israel. J. Neuroophthalmol. 2001; 21(1):12–4.
  77. Killer H.E., Laeng H.R., Groscurth P. Lymphatic capillaries in the meninges of the human optic nerve. J. Neuroophthalmol. 1999; 19(4):222–8.
  78. Kleinschmidt J. J., Digre K.B., Hanover R. Idiopathic intracranial hypertension: relationship to depression, anxiety, and quality of life. Neurology. 2000; 54(2):319–24.
  79. Lepore F. E. Unilateral and highly asymmetric papilledema in pseudotumor cerebri. Neurology. 1992; 42(3):676–8.
  80. Lessell S., Rosman P. Permanent visual impairment in childhood pseudotumor cerebri. Arch. Neurol. 1986; 43(8):801–4.
  81. Levin B. E. The clinical significance of spontaneous pulsation of the retinal vein. Arch. Neurol. 1978; 35(1):37–40.
  82. Lochhead J., Elston J.S. Doxycycline induced intracranial hypertension. BMJ. 2003; 326(7390):641–2.
  83. Lorentzen S.E. Incidence of spontaneous venous pulsations in retina. Acta Ophthalmol. 1970; 48(4):765–70.
  84. Lueck C., Mcllwaine G. Interventions for idiopathic intracranial hypertension. Cochrane Database Syst. Rev. 2002; 3:1–12.
  85. Seitz J., Held P., Strotzer M., Muller M., Volk M., Lenhart M. Magnetic resonance imaging in patients diagnosed with papilledema: a comparison of 6 different high–resolution Tl– and T2– weighted 3–dimensional and 2–dimensional sequences. J. Neuroimaging. 2002; 12(2):164–71.
  86. Malayeri A.A., Bavarian S., Mehdizadeh M. Sonographic evaluation of optic nerve diameter in children with raised intracranial pressure. J. Ultrasound Med. 2005; 24(2):143–7.
  87. Mathew N.T., Ravishankar K., Sanin L.C. Coexistence of migraine and idiopathic intracranial hypertension without papilledema. Neurology. 1996; 46(5):1226–30.
  88. Mathews M.K., Sergott R.C., Savino P.J. Pseudotumor cerebri. Cur. Opin. Ophthalmol. 2003; 14(6):364–70.
  89. Maxner C.E., Freeman M.I., Corbett  J.J. Asymmetric papilledema and visual loss in pseudotumor cerebri. Can. J. Neurol. Sci. 1987; 4(4):593–6.
  90. McAlpine D. Toxic hydrocephalus. Brain. 1937;60:180–203.
  91. McDonnell G.V., Patterson V.N., McKinstry S. Cerebral venous thrombosis occurring during an ectopic pregnancy and complicated by intracranial hypertension. Br. J. Clin. Pract. 1997; 51(3):194–7.
  92. Mezaal M., Saadah M. Idiopathic intracranial hypertension in Dubai: nature and prognosis. Acta Neurol. Scand. 2005;112(5):298–302.
  93. Miller N., Newman N. Neuroophthalmology. 5–nd ed. Baltimore: Williams and Wilkins; 1998. 694 p.
  94. Monteiro M.L.R., Moura F.C. Ophthalmic aspects of idiopathic intracranial hypertension syndrome (pseudotumor cerebri). Rev. Bras. Oftalmol. 2008; 67(4):196–203.
  95. Gass A., Barker G., Riordan–Eva P. MRI of the optic nerve in benign intracranial hypertension. Neuroradiol. 1996; 38(8):769–773.
  96. Mulholland D. A., Craig J.J., Rankin J.A.Use of scanning laser ophthalmoscopy to monitor papilloedema in idiopathic intracranial hypertension. Br. J. Ophthalmol. 1998; 82(11):1301–5.
  97. Neville B.G., Wilson G. Benign intracranial hypertension following corticosteroid withdrawal in childhood. BMJ. 1970; 3(722):554–6.
  98. Newborg B. Pseudotumor cerebri treated by rice reduction diet. Arch. Intern. Med. 1974;133(5):802–7.
  99. Nonne M. About the case of symptomocomplex "Tumor Cerebri'' with output in Helling (pseudotumour cerebri). About runny lethal case of ''Pseudotumour Cerebri'' with Autopsy. Dtsch. Zeit. f. Nervenheil. 1904;27(3–4):169–216.
  100. Orcutt J. C., Page N.G.R., Sanders M.D. Factors affecting visual loss in benign intracranial hypertension. Ophthalmology. 1984; 91(11):1303–12.
  101. Buchheit W. A., Burton C., Haag B. Shaw D. Papilloedema and idiopathic intracranial hypertension: Report of a familial occurrence. NEJM. 1969; 280:938–41.
  102. Gu X.Z., Tsai J.C., Wurdeman A., Wall M., Foote T., Sadun A.A. Pattern of axonal loss in longstanding papilledema due to idiopathic intracranial hypertension. Curr. Eye Res. 1995; 14(3):173–80.
  103. ?ncecik F., Herguner O., Karagun B., Altunbasak S. Pseudotumor Cerebri Associated with Vitamin B12 Deficiency. Eur. J. Gen. Med. 2014;11(2):121–2.
  104. Arseni C., Simoca I., Jipescu I., Leventi E., Grecu P., Sima A. Pseudotumor cerebri: risk factors, clinical course, prognostic criteria. Rom. J. Neurol. Psychiatry. 1992; 30(2):115–32.
  105. Purvin V. A. Kawasaki A., Yee R.D.  Papilledema and obstructive sleep apnea syndrome. Arch Ophthalmol. 2000; 118(12):1626–30.
  106. Trick G.L., Vesti E., Tawansy K., Skarf B., Gartner J. Quantitative evaluation of papilledema in pseudotumor cerebri. Invest. Ophthalmol. Vis. Sci. 1998; 39(10):1964–71.
  107. Quigley H.A., Addicks E.M., Green W.R. Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy. Arch. Ophthalmol. 1982; 100(1):135–146.
  108. Quincke H. About serous meningitis and related conditions. Dtsch. Zeit. f. Nervenheil. 1897; 9(3–4):149–68.
  109. Bruce, B. B., Preechawat P., Newman N. J.,Lynn M.J.,Biousse V. Racial differences in idiopathic intracranial hypertension. Neurology. 2008; 70(11):861–7.
  110. Selhorst J. B., Kulkantrakorn K., Corbett J.J., Leira E.C., Chung S.M. Retinol–binding protein in idiopathic intracranial hypertension (IIH). J. Neuroophthalmol. 2000; 20(4):250–2.
  111. Rosenfeld E., Kesler A. Pseudotumor cerebri (idiopathic intracranial hypertension) an update. Neuroimaging. Clinical Applications. 2010; 6:373–400.
  112. Rowe F.J., Sarkies N.J. Visual outcome in a prospective study of idiopathic intracranial hypertension. Arch Ophthalmol. 1999; 117(11):1571.
  113. Rush J.A. Pseudotumour cerebri: clinical profile and visual outcome in 63 patients. Mayo. Clin. Proc. 1980; 55(9):541–6.
  114. Schirmer C. M., Hedges T.R. Mechanisms of visual loss in papilledema. Neurosurg. Focus. 2007; 23(5):5.
  115. Jacobson D. M., Berg R., Wall M., Digre K.B., Corbett J.J., Ellefson R.D. Serum vitamin A concentration is elevated in idiopathic intracranial hypertension. Neurology. 1999; 53(5):1114–1118.
  116. Smith T.J., Baker R.S. Perimetric findings in pseudotumor cerebri using automated techniques. Ophthalmology. 1986; 93(7):887–94.
  117. Munk P.L., Vellet A.D., Levin M., Lin D.T., Collyer R.T. Sonography of the eye. American Journal of Roentgenology 1991;157(5):1079–1086.
  118. Sorensen P. S., Thomsen A.M., Gjerris F.Persistent disturbances of cognitive functions in patients with pseudotumour cerebri. Acta. Neurol. Scand. 1986;73(3):264–8.
  119. Bulens C., Meerwaldt J. D., Koudstaal P.J., Van der Wildt G.J. Spatial contrast sensitivity in benign intracranial hypertension. J. of Neurology, Neurosurgery & Psychiatry. 1988; 51(10):1323–9.
  120. Standridge S. Idiopathic intracranial hypertension in children: a review and algorithm. Pediatr. Neurol. 2010; 43(6):377–90.
  121. Stone M.B. Ultrasound diagnosis of papilledema and increased intracranial pressure in pseudotumor cerebri. Am. J. Emerg. Med. 2009; 27(3):e1–376.
  122. Symonds C. P. Otitic hydrocephalus. Brain. 1931; 54:55–71.
  123. Giuseffi V., Wall M., Siegel P.Z., Rojas P.B. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumour cerebri): A case–control study. Neurology. 1991; 41(2):239–44.
  124. Thapa R., Ghosh A., Mukherjee S. Childhood hepatitis A virus infection complicated by pseudotumor cerebri. South. Med. J. 2009; 102(2):204–5.
  125. Thapa R. ,Mallick D., Biswas B. Pseudotumor cerebri in childhood hepatitis E virus infection. Headache. 2009; 49(4):610–1.
  126. Kesler A., Goldhammer Y., Hadayer A., Pianka P. The outcome of pseudotumor cerebri induced by tetracycline therapy. Acta. Neurol. Scand. 2004; 110(6):408–11.
  127. Rubin R. C., Henderson E.S., Ommaya A.K., Walker M.D., Rall D.P. The production of cerebrospinal fluid in man and its modification by acetazolamide. J. Neurosurg. 1966; 25(4):430–6.
  128. Girisgin A.S., Kalkan E., Kocak S., Cander B., Gul M., Semiz M. The role of optic nerve ultrasonography in the diagnosis of elevated intracranial pressure. Emerg. Med J. 2007; 24(4):251–4.
  129. Johnson L. N., Krohel G. B., Madsen R.W., March G.A. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology. 1998; 105(12):2313–17.
  130. Karakitsos D., Soldatos T., Gouliamos A., Armaganidis A, Poularas J, Kalogeromitros A, Boletis J, Kostakis A, Karabinis A. Transorbital sonographic monitoring of optic nerve diameter in patients with severe brain injury. Transplant. Proc. 2006; 38(10):3700–6.
  131. Celebisoy N., Gokcay F.,Sirin H., Akyurekli O. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open–label study. Acta Neurol Scand. 2007; 116(5):322–7.
  132. Tamburrelli C., Salgarello T., Caputo C. G., Giudiceandrea A., Scullica L. Ultrasonographic evaluation of optic disc swelling: comparison with CSLO in idiopathic intracranial hypertension. Invest. Ophthalmol. Vis. Sci. 2000; 41(10):2960–6.
  133. Geeraerts T., Launey Y., Martin L., Pottecher J, Vigue B, Duranteau J, Benhamou D. Ultrasonography of the optic nerve sheath may be useful for detecting raised intracranial pressure after severe brain injury. Intensive Care Med. 2007; 33(10);1704–11.
  134. Yau G., Lee J., Chan T., Yuen C. Unilateral papilledema and choroidal folds: an uncommon presentation of idiopathic intracranial hypertension. Surgery Curr. Res. 2014; 4(4):193–5.
  135. Vartzelis G., Lancaster D., Fallon P.Intracranial hypertension in pediatric patients with acute lymphoblastic leukemia. Pediatr. Blood Cancer. 2009; 52(3):418–20.
  136. Lazzaro M.A., Darkhabani Z., Remler B.F., Hong S.H., Wolf T.J.,Zaidat O.O, Fitzsimmons B. Venous sinus pulsatility and the potential role of dural incompetence in idiopathic intracranial hypertension. Neurosurgery. 2012; 71(4):877–84.
  137. Corbett J. J., Savino P. J., Thompson H. S., Kansu T, Schatz N.J, Orr L.S, Hopson D. Visual loss in pseudotumor cerebri. Arch. Neurol. 1982; 39(8):461–74.
  138. Baker R.S., Carter D., Hendrick E.B., Buncic J.R. Visual loss in pseudotumour cerebri of childhood: a follow up study. Arch. Ophthalmol. 1985; 103:1681–6.
  139. Walker R. W. Idiopathic intracranial hypertension: any light on the mechanism of the raised pressure? J. Neurol. Neurosurg. Psychiatry. 2001; 71(1):1–5.
  140. Wall M., White W.N. Asymmetric papilledema on idiopathic intracranial hypertension: prospective interocular comparison of sensory visual function. Invest. Ophthalmol. Vis. Sci. 1998; 39(1):134–42.
  141. Wall M. Idiopathic intracranial hypertension. Neurol. Clin. 1991; 9(1):73–95.
  142. Wall M., George D. Idiopathic intracranial hypertension: A prospective study of 50 patients. Brain. 1991; 114:155–80.
  143. Wall M., Hart W.M., Burde R.M. Visual field defects in idiopathic intracranial hypertension (pseudotumour cerebri). Am. J. Ophthalmol. 1983; 96(5):654–69.
  144. Wall M., George D. Visual loss in pseudotumor cerebri: incidence and defects related to visual field strategy. Arch. Neurol 1987; 44(2):170–5.
  145. Walsh F. Clinical Neuroophthalmology. 1nd ed. Baltimore: Williams&Wilkins; 1969. 667p.
  146. Weisberg L.A. Benign intracranial hypertension. Medicine. 1975; 54(3):197–207.
  147. Winner P., Bello L.Idiopathic intracranial hypertension in a young child without visual symptoms or signs. Headache. 1996; 36(9):574–6.
  148. Worrell J., Lane S. Impact of pseudotumor cerebri (idiopathic intracranial hypertension) in pregnancy: a case report. AANA J. 2007; 75(3):199–204.
  149. Zamecki K.J., Frohman L.P., Turbin R.E. Severe visual loss associated with idiopathic intracranial hypertension (IIH) in pregnancy. Clin. Ophthalmol. 2007; 1(2):99–103.